Cohance Lifesciences (BOM:543064) Marketable Securities : ₹0 Mil (As of Dec. 2024)

View and export this data going back to 2020. Start your Free Trial

What is Cohance Lifesciences Marketable Securities?

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Cohance Lifesciences's Marketable Securities for the quarter that ended in Dec. 2024 was ₹0 Mil.

Cohance Lifesciences's annual Marketable Securities declined from Mar. 2022 (₹4,812 Mil) to Mar. 2023 (₹4,189 Mil) but then increased from Mar. 2023 (₹4,189 Mil) to Mar. 2024 (₹7,739 Mil).

Cohance Lifesciences Marketable Securities Historical Data

The historical data trend for Cohance Lifesciences's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cohance Lifesciences Marketable Securities Chart

Cohance Lifesciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Marketable Securities

Get a 7-Day Free Trial

306.73

1,805.94

4,812.22

4,189.35

7,738.96

Cohance Lifesciences Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Marketable Securities	Get a 7-Day Free Trial															-	7,738.96	-	6,361.60	-

Cohance Lifesciences Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Cohance Lifesciences (BOM:543064) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Cohance Lifesciences Marketable Securities Related Terms

Thank you for viewing the detailed overview of Cohance Lifesciences's Marketable Securities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cohance Lifesciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cohance Lifesciences Ltd (BOM:543064) » Definitions » Marketable Securities

Traded in Other Exchanges

SUVENPHAR:India

Address

No. 202, A-Wing, Galaxy Towers, Plot No.1, Hyderabad Knowledge City, TSIIC, Raidurg, Hyderabad, TG, IND, 500081

Website

https://www.suvenpharm.com

Suven Pharmaceuticals Ltd is involved in developing and manufacturing intermediates, active pharmaceutical ingredients (API), specialty chemicals, and formulated drugs under Contract Research and Manufacturing Services (CRAMS) for global pharmaceutical, biotechnology, and chemical companies. The company operates majorly in the Manufacturing (CRAMS) segment, which includes bulk drugs and intermediates under contract services. Its geographical segments include India, the USA, Europe, and the Rest of the World. The majority of the company's revenue comes from the Europe segment.

Cohance Lifesciences Headlines

No Headlines